Description
Next-generation
sequencing (NGS) is a DNA sequencing technology, which has emerged as a vital
element in genomic research. It is gaining prominence as an everyday research
tool among researchers to study biological systems at a more rapid pace than
conventional sequencing methods such as Sanger sequencing
Request Free Sample Copy – https://www.radiantinsights.com/research/global-next-generation-sequencing-ngs-market-report-and-forecast-to-2021/request-sample
Utilization
of the NGS technology in IVD systems for clinical applications is likely to
witness a sharp rise. For instance, in November 2017, Illumina, Inc. announced
the launch of its NextSeq™ 550Dx instrument, a CE-IVD marked and FDA-regulated
NGS system for the development of an array of IVD assays.
Lower Turnaround Time to Make Targeted
Sequence a Highly Preferred Product
Next-generation
sequencing is used to describe a number of different modern sequencing
technologies, including targeted sequencing, transcriptome sequencing, and
exome sequencing. Demand for targeted sequence is likely to remain high for
coming years. Declining sequencing costs and rising awareness regarding its
advantages such as manageable data sets and lower turnaround time can
contribute to the growth of the segment. Increasing number of projects being
undertaken pertaining to protein expression analysis is translating into the
greater uptake of targeted sequencing. Soaring need for analysis of smaller
dataset can also supplement the growth of the segment.
Adoption
rate of exome sequencing is likely to increase at a noteworthy pace in the near
future. The growth of the segment can be attributed to rising research and
development activities aimed at mapping human and non-human genomes. Uptake of
exome sequencing is high for the study of rare Mendelian disorders as it is an
effective way to detect genetic variants in the genes of an individual. Rapid
technological advancements will also benefit the growth of the segment.
Market Insights
Increasing
efforts by companies to boost awareness regarding NSG services and products
through workshops and seminars can escalate the growth of the next-generation
sequencing (NGS) market. Rising R&D activities promoting advancements in
the field of metabolomics, transcriptomics, and proteomics are likely to
provide a fillip to the market. Genomics and proteomics operate with the help
of extensive structural information that needs to be gathered and arranged by
means of determination of sequence and subsequent integrated data analysis
View Full Report at- https://www.radiantinsights.com/research/global-next-generation-sequencing-ngs-market-report-and-forecast-to-2021
As
per the findings of a report added to Radiant Insights, Inc.; Asia Pacific is
likely to remain a promising region during the forecast period (2017 to 2021).
Improving healthcare infrastructure is anticipated to drive the market in the
region. Some of the prominent companies in the market are CapitalBio
Corporation, Thermo Fisher Scientific, Berry Genomics Co. Ltd., Roche, and
Qiagen
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the basis
of extensive and in-depth quantitative information, supported by extensive
analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
Web: http://www.radiantinsights.com
No comments:
Post a Comment